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Abstract
Objectives: To diagnose Legionella infection and determine its 
incidence and risk factors in community-acquired pneumonia (CAP) 
patients hospitalized in the chest department and hospital-acquired 
pneumonia (HAP) patients admitted to the emergency and surgery 
ICU of Zagazig University Hospital. Additionally, the study determines 
the occurrence of Legionella genus in the water of this department. 
Subjects and methods: One hundred clinically diagnosed pneumonic 
patients; 50 patients with CAP and 50 with HAP were the subjects 
of this laboratory-based, comparative cross sectional study. Full clinical 
history and lower respiratory tract specimens were collected from each 
patient. Water samples were taken from 25 water outlets. DNA was 
extracted by QIAamp DNA Mini Kit, and real time PCR amplification 
of 16s r-RNA gene was used for diagnosis of Legionella genus. Risk 
factors were analyzed by logistic regression analysis.
Results: Legionella genus was identified in 8 / 50 patients of CAP 
(16%), and 10/ 50 patients with HAP (20%). In CAP patients, the 
organism was prevalent in old- age, smoker males, with diabetes 
mellitus (DM) and/or chronic obstructive pulmonary disease (COPD). 
Gastrointestinal tract (GIT) and neurological manifestations were 
the main presentations. Seventy-five percent of these patients were 
admitted to ICU. For patients with HAP, hospitalization for more than 
ten days and having a stroke or head trauma were significant risk 
factors. Ten out of the 25 water samples tested were positive for 
Legionella genus; seven samples were from the chest department 
and three were from emergency ICU. No water-contamination with 
Legionella was found in the surgery ICU.
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Introduction
Legionella is the causative agent of Legionnaires’ 
disease (LD) and Pontiac fever [1]. Although most 
cases are caused by L. pneumophila, other species 
are also pathogenic [2-4]. Legionella bacteria are 
intracellular pathogens; antimicrobial agents that 
achieve intracellular concentrations higher than the 
minimal inhibitory concentration (MIC) are effec-
tive for their treatment, especially macrolides and 
quinolones [5]. The activities of levofloxacin and 
azithromycin are similar and both are considered 
the first-line therapy [6-7]. Patients with legionnaire 
disease who do not receive appropriate antibiotics 
can have bad prognosis and high mortality rate [8].
Legionellosis can be diagnosed with many mo-
dalities [9]. However, data from developing world 
are scarce [10]. Detection of Legionella in water 
sources could be used as a predicting risk factor 
for LD [11-12].
In Egypt, the magnitude of legionellosis is not 
well recognized. Additionally, the few previous stud-
ies carried out addressed only L. Pneumophila [13, 
14]. In Zagazig university hospital, to our knowl-
edge, there is no information either on the preva-
lence and risk factors, or on water contamination 
with the general genus of Legionella. 
The objectives of this study were to determine 
the incidence of Legionella genus among patients 
with pneumonia; both in community- and hospital- 
acquired and to identify risk factors associated with 
this infection. Additionally to determine the occur-
rence of Legionella genus in the water sources.
Subjects and Methods 
The study was conducted over the period from 
January 2013 to January 2015 in the Zagazig Uni-
versity Hospital; which has 1800 bed capacity. It 
is a university-affiliated hospital located in Sharkya 
Governorate / eastern province of Egypt, with a 
catchment area of about 7 millions. The study was 
conducted under the supervision of both microbiol-
ogy and chest departments.
Subjects 
One hundred diagnosed pneumonic patients 
were enrolled in this laboratory-based, comparative 
cross sectional study. Fifty patients were diagnosed 
as CAP because they were admitted to the chest 
department with pneumonia. HAP cases were 50 
patients who acquired pneumonia after a minimum 
of 7 days after admission to emergency ICU or sur-
gery ICU and were diagnosed to have nosocomial 
pneumonia [15]. Complete medical history and clini-
cal data were collected from all patients using a 
pre- prepared sheet.
Inclusion criteria were the presence of at least 
one of the major criteria for diagnosis of pneumo-
nia, and these include; cough, sputum production, 
temperature >37.8°C or presence of at least two 
Conclusion: Diagnosis of Legionella should be considered for both 
CAP and HAP in our hospital. Periodic surveillance for detection of 
this organism with subsequent disinfection of water sources should 
be carried out.
Key-words: Legionella, Real time PCR, Water, Egyptian Patients   
THE INTERNATIONAL ARABIC JOURNAL OF ANTIMICROBIAL AGENTS
ISSN 2174-9094
2016
Vol. 6 No. 2:1
doi: 10.3823/786
© Under License of Creative Commons Attribution 3.0 License 3
of the minor criteria as follow: pleuritic chest pains, 
dyspnea, pulmonary consolidation by physical ex-
amination, and white blood cell count of > 12000 
cells/μl or pulmonary infiltrate seen on a chest ra-
diograph. 
Exclusion criteria were patient who refused treat-
ment, diagnosed with tuberculosis or human im-
munodeficiency virus (HIV) infection and those with 
age of < 5 years.
This study was approved by Institutional Re-
view Board (IRB) Committee of Zagazig Faculty of 
Medicine. An informed written consent was taken 
from each patient or his/her guardian after being 
informed about the nature as well as the purpose of 
the study. Participants’ data was kept confidential.
Clinical samples collection 
Lower respiratory tract specimens were collected 
using standard Microbiologic procedures and stored 
at -20°C until processed [16].
Environmental water samples collection 
One litre water samples were collected from 25 
water outlets in chest department, emergency ICU 
and surgery ICU using standard Microbiologic proce-
dures and filtered through a membrane filter (0.45 
mm pore size, Millipore corporation, Bedford, USA) 
in a stainless-steel filter holder with a water aspirator. 
After filtration, membranes were placed into 5ml of 
sterile water and scraped to remove bacteria. The 
concentrate was stored at -20 °C until used [17].
DNA extraction 
Bacterial DNA was extracted directly from both 
clinical and water samples using QIAamp DNA Mini 
Kit (Qiagen, Courtaboeuf, France). Procedures fol-
lowed the instructions of the manufacturer.
Real time PCR of 16s r-RNA gene 
Legionella genus was detected in DNA extracts 
by real time PCR amplification of 16s r-RNA gene 
using Primerdesign™ genesig® Kit for Legionella 
(all species) (PrimerDesign, UK) whose anchor nucle-
otide information is; accession number: DQ123630, 
anchor nucleotide: 71 and context length: 157bp. 
Procedures were done according to the manufac-
turer’s instructions. For the negative control reac-
tion; RNAse/DNAse free water (supplied in the kit) 
was used. The following amounts were added to 
each reaction; ten μL of RT-PCR Master mix, one μL 
of the primer/probe, four μL of distilled water free of 
RNAse/DNAse and five μL of the DNA extract. The 
device used was Real-time PCR instrument Strata-
gene Mx 3005P (Agilent technologies, USA). The 
protocol used for amplification was enzyme activa-
tion at 95°C for ten minutes followed by 50 cycles 
of denaturation at 95°C for ten seconds and data 
collection at 60°C for 60 seconds. The results of 
the real-time PCR were expressed as threshold cy-
cle (CT) values corresponding to the cycle at which 
PCR enters the exponential phase. If no increase in 
fluorescent signal is observed after 50 cycles, the 
sample is assumed to be negative. 
Clinical data and risk factors 
determination  
Using statistical analyses listed below, the follow-
ing comparisons were done:
Signs and symptoms of cases of community ac-
quired legionellosis versus those among cases of 
CAP due to other causes. 
Risk factors for community acquired legionello-
sis versus those among cases of CAP due to other 
causes. 
Clinical outcome for community acquired le-
gionellosis versus those among cases of CAP due 
to other causes. 
Risk factors for hospital acquired legionellosis ver-
sus those among cases of HAP due to other causes. 
Statistical Analysis 
Collected data were computerized and statisti-
cally analyzed using SPSS program (Statistical Pack-
age for Social Science) version 18.0. Qualitative 
data were represented as frequencies and relative 
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Figure 1. Distribution of cases of CAP and HAP.
percentages. Chi square test was used to calculate 
difference between qualitative variables. Quantita-
tive data were expressed as mean ± SD (Standard 
deviation). Logistic regression analysis was used to 
illuminate the interrelation within and between sig-
nificant predictors for specific variable. The level of 
significance for all statistical tests was determined. 
The threshold of significance is fixed at 5% level 
(P-value); P > 0.05 indicates non-significant results, 
P-value of <0.05 indicates significant results.
Results 
Real time PCR results revealed that out of the 
50 patients with CAP, eight patients’ samples were 
positive for Legionella genus, whereas 10 out of 
50 of patients with HAP were positive (20%); six of 
them were in emergency ICU (27.3%), while four 
patients were in surgery ICU (14.3%) (Figure 1). 
Real time PCR amplification plot is shown in (Fig-
ure 2).
Characters of cases of community acquired LD 
compared to CAP due to other causes are shown 
in table 1. Cases with Legionella CAP were more 
likely to be smoker and diabetic males of old age 
who are immune- suppressed with COPD, and/or 
malignancy. They were more likely to present with 
fever, non-productive cough, GIT and neurological 
manifestations. Cases with Legionella CAP were 
more likely to require ICU admission. When bina-
ry logistic regression analysis was made, smoking, 
male gender, old age, diabetes mellitus and COPD 
remained significantly associated with Legionella 
CAP, table 2.
When risk factors for hospital acquired legionel-
losis were compared with HAP due to other caus-
es; hospitalization for more than 10 days, stroke or 
head trauma and heart disease were significantly 
associated with hospital- acquired LD, table 3. Bi-
nary logistic regression analysis for risk factors of 
hospital acquired LD revealed that hospitalization 
for more than 10 days, stroke or head trauma are 
the significant risk factors, table 4.
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Figure 2. Amplification plot of real time PCR. The results of the real-time PCR are expressed as threshold cycle (CT) values 
corresponding to the cycle at which PCR enters the exponential phase. If no increase in fluorescent signal is observed after 50 
cycles, the sample is assumed to be negative. The horizontal axis represents 50 cycles of amplification while the vertical axis 
represents fluorescent signal. This figure shows positive control (CT 25.6), a number of positive cases (variable CTs), negative 
control (no CT) and a number of negative cases (no CT) (negative control and negative cases are overlapping the horizontal axis 
of the plot marked by the red arrow) 
Ten out of the 25 water samples tested were 
positive for Legionella genus; 7 were from chest 
department. The remaining three were from emer-
gency ICU. 
Discussion
Studies about LD are rare in the developing 
world, and the problem of Legionella is undoubt-
edly underestimated [4]. Although L. pneumophila 
serogroup 1 is the most common human pathogen 
of the genus Legionella; it is possible that, under 
favourable situations, the majority of other species 
and serotypes are also incriminated in Legionnaires’ 
disease due to their competency for cellular invasion 
and intracellular proliferation [18, 2].
Investigated patients suffering from CAP and 
needing hospitalization were admitted to the chest 
department. HAP patients were recruited from 
emergency and surgery departments because both 
have the biggest ICUs in our hospital. Moreover, 
there were complaints of the high frequency of HAP 
in these two departments and we have no previous 
information about occurrence of Legionella in our 
hospital.
The diagnosis of Legionella infection can be 
done by a number of investigation arrays. Bacte-
rial culture is considered the most specific means, 
but it is associated with long time, low sensitivity 
and technical difficulty. Direct Fluorescent-Antibody 
(DFA) test is much more rapid than culture, but it 
has poor sensitivity. Radioimmunoassay, enzyme 
immunoassay, and latex agglutination can be used 
for detection of only L. pneumophila (serogroup 1) 
in urine with a moderate sensitivity. Serologic meth-
ods are extremely sensitive, but these require long 
time to detect seroconversion in patients. Analyzes 
based on molecular diagnostics have emerged re-
cently. Conventional molecular techniques are la-
bor intensive and often need at least 1 day to be 
achieved. Additionally, the obligatory manipulation 
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of post-amplification products escalates the hazards 
of carryover contamination and consequently false 
positivity. Currently, using real-time PCR instrumen-
tation allows amplification and identification in a 
single sealed cuvette. This method eliminates the 
necessity for additional manipulation of the speci-
mens, significantly diminishes turnaround time and 
reduces the risk of cross-contamination in samples. 
Recent reports confirmed that real-time PCR meth-
ods are attractive substitutions to conventional PCR 









Male sex 6 (75%) 14 (33.3%) 0.04
Age (Mean ± Standard Deviation) 49.7 ± 10.3 47.5 ± 1.7 <0.04
Underling medical 
condition
Diabetes mellitus 3 (37.5%) 3 (7.1%) 0.02
Hypertension 2 (25%) 6 (14.3%) 0.86
COPDd 2 (25%) 1 (2.4%) 0.01
Smoking 4 (50%) 6 (14.3%) 0.03
Immune suppression 1 (12.5%) 0 (0%) 0.02
Malignancy 1(12.5%) 0 (0%) 0.02
Stroke or head trauma 0 (0%) 3 (7.1%) 0.44
Heart disease 1 (12.5%) 9 (21.4%) 0.92
Liver disease 0 (0%) 6 (14.3%) 0.59
Kidney disease 1 (12.5%) 3 (7.1%) 0.84
Signs and symptoms Fever>38 8 (100%) 26 (61.9%) 0.03
Cough 5 (62.5%) 29 (69%) 0.72
Sputum 1(12.5%) 22 (52.4%) 0.04
Dyspnea 4 (50%) 24 (57%) 0.71
Chest pain 1(12.5%) 4 (9.5%) 0.78
GIT manifestatione 3 (37.5%) 4 (9.5%) 0.03
Neur. manifestationsf 2 (25%) 1 (2.4%) 0.01
Clinical outcome ICU stay 6 (75%) 14 (33.3%) 0.04
Ventilator support 5 (62.5%) 17 (40.5%) 0.11
a community acquired legionellosis 
b other causes of community acquired pneumonia
c P-value of <0.05 indicates significant results, P-value of <0.01 indicates highly significant results
d Chronic obstructive pulmonary disease
e Gastrointestinal tract manifestations 
f Neurological manifestations 
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techniques [19]. Therefore, real time PCR was used 
for the identification of the genus Legionella in this 
study. 
The gene amplified in the current work; 16S 
rRNA gene is exceptionally suited as a target for 
identification of the genus Legionella since it is 
highly conserved and exists in several copies per 
genome and thus allows a high sensitivity of the 
PCR in both clinical and environmental water sam-
ples. However, the variation in the 16S rRNA is not 
large enough to resolve strains or serogroups within 
a genus. For species identification, other methods 
need to be applied [20, 21]. Since Legionella is not 
a part of the normal human flora, quantification 
was not indicated for clinical samples and presence 
or absence of the organism could be considered 
satisfactory [22].
The rate of isolation of Legionella genus (16%) 
among our CAP patients is shown in figure 1. It is 
higher than that of an earlier Egyptian study (5% 
with CAP) [13]. The lower incidence of the previous 
study could be attributed to their method of inves-
tigation which has focused only on L. pneumophila. 
Few countries of the world consider LD a notifi-
able disease, and incidence of L. pneumophila and 
other species can be obtained, whereas, most other 
countries have rare data because of lack of diagnos-
tics and surveillance systems. It is worth mentioning 
that the worldwide occurrence of Legionnaires’ dis-
ease is challenging to measure and attention should 
be taken in explanation of the surveillance figures 
[10].
Similar to many previous reports, our study 
showed that community acquired legionellosis was 
more common in old- age and smokers male pa-
tients (Tables 1 & 2). Smoking as a risk factor for 
legionellosis was found in previous studies as the 
following, 63%, 25% and 15.4%, respectively [23-



















b Standard error around the coefficient for the constant
c Wald chi-square test statistic




h Chronic obstructive pulmonary disease
i Gastrointestinal tract manifestation
j Neurological manifestations
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25]. Smoking raises the risk of legionellosis by 121% 
for each pack of cigarettes used up daily. This in-
creased risk is due to the difficulty in eliminating the 
microorganism from the bronchial tree, due to the 
worsening of the respiratory mucosa and weakened 
cilia caused by tobacco smoking that facilitates entry 
into and subsequent invasion of the alveolar mac-
rophages, depending on the individual’s immune 
rank [26]. In the current study, diabetes was a signif-
icant risk factor for legionellosis (Table 1 & 2). This 
result is in agreement with former studies which 
showed that diabetes was detected in 23-41% of 
patients [23-25]. Diabetic patients were found to be 
at increased risk of legionellosis due to impaired cell 
mediated immunity [27]. This study found that COPD 
was another risk factor (Table 1 & 2) which agrees 
with the study of Maniwa et al. who reported that 
21% of patients with LD suffered from COPD [23], 
while other authors reported lower rates of COPD 
occurrence [25]. Chronic renal disease, having a pre-
vious stroke, hypertension and malignancy were not 
significant risk factors in our study as compared to 
other investigations [23, 25]. The diversity of results 
may be related to variable environmental exposure 
or due to variable susceptibility of different popula-
tions [21].
In this study, clinical presentations of patients 
with community acquired legionellosis have similar 
features to other reported studies (Table 1 & 2). In 
addition, GIT and neurologic symptoms were previ-
ously reported in LD, with a range of 20% to 50% 
[23-25, 27-30], whereas our finding showed that 
75% of patients with community-acquired legionel-
losis were admitted to ICU, and this factor is com-
parable with other studies [25]. This result can be 
attributed to old age and underlying co-morbidity 
of patients with legionella pneumonia which causes 
severe disease [31].









Age (Md ± SDe) 37.4 ± 12.7 34.5 ± 10.3 0.54
Male sex 8 (80%) 28 (70%) 0.66
Diabetes mellitus 1 (10%) 14 (35%) 0.24
Hypertension 2 (20%) 8 (20%) 0.95
COPDf 1 (10%) 5 (12.5%) 0.83
Smoking 5 (50%) 13 (32.5%) 0.57
Hospitalization ≥ 10 ds 9 (90%) 12 (30%) <0.001
Intubation 9 (90%) 31 (77.5%) 0.66
Immune suppression 1 (10%) 1 (2.5%) 0.86
Malignancy 1 (10%) 13 (32.5%) 0.31
Stroke or head trauma 6 (60%) 10 (25%) 0.03
Heart disease 4 (40%) 2 (5%) 0.002
Liver disease 1 (10%) 3 (7.5%) 0.79
Kidney disease 1 (10%) 1 (2.5%) 0.86
a Hospital acquired legionellosis 
b Other causes of hospital acquired pneumonia
c P-value of <0.05 indicates significant results, P-value of <0.01 indicates highly significant results
d Mean
e Standard deviation
f Chronic obstructive pulmonary disease
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The current incidence of hospital-acquired LD 
(figure 1) falls within previous reported rates which 
were reported between one to 40% of cases [1, 
32]. This wide range of occurrence stated by those 
studies probably reflects the difficulty of accurate 
estimation of such cases. Centres for Disease Con-
trol and Prevention (CDC) estimate that less than 
ten percent of hospital-acquired LD cases are actu-
ally reported [33]. 
It was not possible to compare between clinical 
manifestations of HA- Legionella patients versus HA 
non-Legionella cases due to difficulty in collecting 
data particularly in ICU settings [31]. Hospitalization 
for more than 10 days was a major risk factor for 
hospital acquired legionellosis (Table 3 & 4) [34]. 
Stroke or head trauma was also a significant risk 
factor, a finding that could be attributed to the im-
paired conscious level which is linked with higher 
frequency of aspiration. 
Fortunately, the early empirical antibiotics used 
for treatment of pneumonia patients in our hospital 
according to the guidelines of the American Tho-
racic Society and the Infectious Diseases Society of 
America for CAP [fluoroquinolone or (beta- lactam 
plus macrolide) [35], and HAP (beta- lactam plus 
fluoroquinolone) [15], included drugs that are effec-
tive against Legionella infection.
Nosocomial Legionella infection can occur through 
aerosol formation or aspiration. The water samples 
collected in this work were obtained from potable 
outlets (tap water). The presence of Legionella in 
the hospital potable water has been suspected as 
the only certain risk factor for contracting hospi-
tal acquired LD [11, 12]. Moreover, in our hospital, 
all water used for general care of patients is the 
potable water, particularly for cleaning and filling 
humidifiers, respiratory devices, nebulizers, bathing, 
toilet flushing and nasogastric and endotracheal in-
tubation. Therefore, if tap water is contaminated, 
Legionella can easily spread and cause infection in 
susceptible hosts [36, 37].
This study is the first work investigating the pres-
ence of Legionella genus in the water of our hospi-
tal. It has been concluded that L. pneumophila and 
Legionella species other than pneumophila may be 
isolated together or alone from water [38, 39], since 
presence of L. anisa may mask water contamination 
by L. pneumophila [40]. Knowing that our surgery 
ICU is a new building located away from the other 
2 departments can provide an answer to the ques-
tion, why water sources in the surgery ICU are free 
of Legionella genus. Based on our findings and on 
the fact that there is no person-to person transmis-
sion of Legionella, we assume that the positive cases 
in the surgery ICU may have acquired the infection 
during their hospitalization in the pre- operative pe-
riod, or during the operation itself. Therefore, unless 
sound infection control policies and procedures are 
Table 4.  Binary logestic regression analysis for significant predictors of hospital acquired legionellosis:
95.0%              C.I.fExpBeSig.dWaldcS.EbBaVariable
UpperLower
5.1051.1092.3790.0057.8490.345-0.967Hospitalization ≥ 10 ds
5.5911.0482.4200.0048.1730.386-1.104Stroke or head trauma
0.9840.4510.7920.5660.3290.411-0.236Heart disease
a Regression coefficients
b Standard error around the coefficient for the constant
c Wald chi-square test statistic
d P-value for Wald test, <0.05 indicates significant results, <0.01 indicates highly significant results
e Expected Beta
f Confidence Interval
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implemented, admission of patients infected with 
Legionella from other hospital areas to the new ICU 
may enhance spreading of legionella infection by 
contamination of diagnostic and therapeutic equip-
ment through Legionella- carrying aerosol.
Conclusions: This study found that old –age, 
smoker– males having CAP with an underlying dia-
betes mellitus and/or COPD and presenting with 
non-productive cough, and GIT and neurological 
manifestation should be considered for Legionella 
infection. Whereas, patients hospitalized for more 
than 10 days, and having a stroke or head trauma 
who acquired HAP should be suspected for Le-
gionella infection. Rigorous infection control meas-
ures are required to keep the water sources in the 
surgery ICU clean to prevent any contamination 
with legionella. 
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